Synchronized cycles of bacterial lysis for in vivo delivery
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The widespread view of bacteria as strictly pathogenic has given way to an appreciation of the prevalence of some beneficial microbes within the human body. It is perhaps inevitable that some bacteria would evolve to preferentially grow in environments that harbor disease and thus provide a natural platform for the development of engineered therapies. Such therapies could benefit from bacteria that are programmed to limit bacterial growth while continually producing and releasing cytotoxic agents in situ. Here we engineer a clinically relevant bacterium to lyse synchronously ata threshold population density and to release genetically encoded cargo. Following quorum lysis, a small number of surviving bacteria reseed the growing population, thus leading to pulsatile delivery cycles. We used microfluidic devices to characterize the engineered lysis strain and we demonstrate its potential as a drug delivery platform via co-culture with human cancer cells in vitro. Asa proof of principle, we tracked the bacterial population dynamics in ectopic syngeneic colorectal tumours in mice via a luminescent reporter. The lysis strain exhibits pulsatile population dynamics in vivo, with mean bacterial luminescence that remained two orders of magnitude lower than an unmodified strain. Finally, guided by previous findings that certain bacteria can enhance the efficacy of standard therapies, we orally administered the lysis strain alone or in combination with a clinical chemotherapeutic to a syngeneic mouse transplantation model of hepatic colorectal metastases. We found that the combination of both circuit-engineered bacteria and chemotherapy leads to a notable reduction of tumour activity along with a marked survival benefit over either therapy alone.Our approach establishes a methodology for leveraging the tools of synthetic biology to exploit the natural propensity for certain bacteria to colonize disease sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An interesting general approach implements engineered bacterial lysis, which enables antitumor protein production or release only when a predefined population density of bacteria is reached (154–157).”
From The microbiome and human cancer (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
A synchronized quorum of genetic clocks
Danino, T., Mondragón-Palomino, O., Tsimring, L., & Hasty, J. (2010) · Nature · doi:10.1038/nature08753 · Cited by 992
Self-citationLeone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, A. F., Nadimpalli, A., Hubert, N., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.006 · Cited by 911
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905 · cited 1×
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citation
Cited by
Items 401–500 of 782
Synthetic microbial consortia based on quorum-sensing for disease therapy
Guo, Y., Gao, M., Jiang, L., Huang, H., Kang, G., & Yu, H. (2025) · Bioresources and Bioprocessing · doi:10.1186/s40643-025-00962-w · Cited by 18
Implantable living materials autonomously deliver therapeutics using contained engineered bacteria
Harimoto, T., Quevedo, F., Zillig, J., Schreiber, S., Wu, Y., Ahn, C. H., To, T., Thakur, R. A., Tatara, A. M., Kang, S., et al. (2026) · Science · doi:10.1126/science.aec2071 · Cited by 22
Prebiotics-Controlled Disposable Engineered Bacteria for Intestinal Diseases
Fang, T.-T., Zou, Z., Zhou, Y., & Ye, B. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00182 · Cited by 15
Engineered oncolytic bacteria for malignant solid tumor treatment
Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 18
Yang, M., Chen, W., Gupta, D., Mei, C., Yang, Y., Zhao, B., Qiu, L., & Chen, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s453709 · Cited by 15
Bacterial Systems as a Precision Delivery Platform of Therapeutic Peptides for Cancer Therapy
Liu, J., Shen, G., & Yan, X. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.4c00026 · Cited by 15
The Expanding Computational Toolbox for Engineering Microbial Phenotypes at the Genome Scale
Zielinski, D., Patel, A., & Palsson, B. (2020) · Microorganisms · doi:10.3390/microorganisms8122050 · Cited by 10
Menghini, S., Ho, P. S., Gwisai, T., & Schuerle, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020498 · Cited by 14
Mackie, G. M., Copland, A., Takahashi, M., Nakanishi, Y., Everard, I., Kato, T., Oda, H., Kanaya, T., Ohno, H., & Maslowski, K. M. (2021) · JCI Insight · doi:10.1172/jci.insight.139900 · Cited by 19
Dichotomous feedback: a signal sequestration-based feedback mechanism for biocontroller design
Sootla, A., Delalez, N. J., Alexis, E., Norman, A., Steel, H., Wadhams, G. H., & Papachristodoulou, A. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0737 · Cited by 13
Reaction processes among self-propelled particles
Peruani, F., & Sibona, G. J. (2018) · Soft Matter · doi:10.1039/c8sm01502c · Cited by 14
Shirai, H., & Tsukada, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.024 · Cited by 15
Autonomous and Assisted Control for Synthetic Microbiology
Banderas, A., Bec, M. L., Cordier, C., & Hersen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239223 · Cited by 13
Unraveling the links between estrogen and gut microbiota in sex-hormone driven cancers
Tahri, A., & Amedei, A. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i9.108819 · Cited by 17
Zi, G., Zhou, W., Zhou, L., Wang, L., Zheng, P., & Wei, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101349 · Cited by 16
Synthetic biology: An emerging field for developing economies
Kiran, B. R., Prasad, M. N. V., & Mohan, S. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16120-9.00013-3 · Cited by 16
Live bacterial therapeutics for detection and treatment of colorectal cancer
Zhang, J. T., Hasty, J., & Zarrinpar, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00901-8 · Cited by 13
Self-citationAdvances of Bacterial Biomaterials for Disease Therapy
Lin, Z., Fu, L., Wei, W., & Zheng, D. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00022 · Cited by 14
Advancing vaccine technology through the manipulation of pathogenic and commensal bacteria
Lloren, K. K. S., Senevirathne, A., & Lee, J. H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101349 · Cited by 21
Neutral drift upon threshold-like selection promotes variation in antibiotic resistance phenotype
Erdoğan, A. N., Dasmeh, P., Socha, R. D., Chen, J. Z., Life, B. E., Jun, R. A., Kiritchkov, L., Kehila, D., Serohijos, A. W. R., & Tokuriki, N. (2024) · Nature Communications · doi:10.1038/s41467-024-55012-4 · Cited by 19
Liu, Z., Lei, L., Zhang, Z., Du, M., & Chen, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101620 · Cited by 20
Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics
Al-Baradie, R. S. (2020) · Human Antibodies · doi:10.3233/hab-200425 · Cited by 14
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
Liu, Z., Hong, L., & Ling, Z. (2023) · Cancer Medicine · doi:10.1002/cam4.6298 · Cited by 13
Challenges at the interface of control engineering and synthetic biology
Steel, H., Lillacci, G., Khammash, M., & Papachristodoulou, A. (2017) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2017.8263791 · Cited by 17
Probiotic-guided CAR-T cells for universal solid tumor targetingPreprint
Vincent, R. L., Gurbatri, C. R., Redenti, A., Coker, C., Arpaia, N., & Danino, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.10.463366 · Cited by 13
Self-citationWang, R., Li, W., Cao, H., & Zhang, L. (2025) · Biology · doi:10.3390/biology14030243 · Cited by 17
Zhao, L., Xin, J., Hu, M., Xue, C., & Dong, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.028 · Cited by 19
The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy
Wang, C., Feng, Q., Shi, S., Qin, Y., Lu, H., Zhang, P., Liu, J., & Chen, B. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401538 · Cited by 15
Precision tumor treatment utilizing bacteria: principles and future perspectives
Liu, Z., Wang, L., Wu, P., & Yuan, L. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13378-x · Cited by 14
Zahedifard, Z., Mahmoodi, S., & Ghasemian, A. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2738 · Cited by 12
Wang, H., Zheng, L., Yang, C., Lin, J. H., Zhou, R., Liu, H., Dong, Y., Xu, X., Shi, G., Yang, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102191 · Cited by 20
Yuan, S., Yang, X., Bremmer, A., Wang, Y., Li, S., Chen, Y., You, Y., & Hu, Q. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507711122 · Cited by 13
Synthetische Biologie – die Synthese der Biologie
Ausländer, S., Ausländer, D., & Fussenegger, M. (2017) · Angewandte Chemie · doi:10.1002/ange.201609229 · Cited by 12
Evolution and synthetic biology
Ornelas, M. Y., Cournoyer, J. E., Bram, S., & Mehta, A. P. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102394 · Cited by 14
Bacterial particles retard tumor growth as a novel vascular disrupting agent
Guo, F., Ji, G., Li, Q., Yang, Y., Shui, L., Shen, Y., & Yang, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109757 · Cited by 12
Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential
Luo, M., Chen, X., Gao, H., Yang, F., Chen, J., & Qiao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980111 · Cited by 10
Fu, Z., Zhang, X., Gao, Y., Fan, J., & Gao, Q. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1320 · Cited by 16
Synthetic engineered bacteria for cancer therapy
Gong, T., & Wu, J. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2241367 · Cited by 12
Martínez, J. A., Bouchat, R., Aurin, T. G. D. S., Martínez, L. C., Caspeta, L., Telek, S., Zicler, A., Gosset, G., & Delvigne, F. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.12.005 · Cited by 12
Ahmadishoar, S., Saeed, S. M., Mahdi, M. S., Taher, W. M., Alwan, M., Jawad, M. J., Hamad, A. K., & Gandomkar, H. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2489979 · Cited by 15
The gut-tumor connection: the role of microbiota in cancer progression and treatment strategies
Wei, Z., Gao, G., He, Q., Kwok, L. Y., & Sun, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.038 · Cited by 14
Electromagnetism and the Microbiome(s)
Siamoglou, S., Boltsis, I., Chassomeris, C. A., & Kambouris, M. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816664-2.00014-1 · Cited by 11
Application of quorum sensing system in microbial synthesis of valuable chemicals: a mini-review
Gu, P., Ma, Q., Zhao, S., Gao, J., Li, C., Zhou, H., Jiang, S., & Li, Q. (2022) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-022-03382-6 · Cited by 11
Nam, J., Lee, Y., Lee, S., Choi, H., Lee, S. Y., & Yang, D. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108782 · Cited by 14
Zhang, Y., Shen, J., Xu, Y., Feng, F., Han, X., Xi, K., Fang, Z., Zhang, Y., Wang, M., Wang, Z., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2025.12.014 · Cited by 11
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Song, J., Zhang, Y., Zhou, C., Zhan, J., Cheng, X., Huang, H., Mao, S., & Zong, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112037 · Cited by 11
Nanomaterial‐assisted oncolytic bacteria in solid tumor diagnosis and therapeutics
Zeng, X., Chen, Q., & Chen, T. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10672 · Cited by 10
Jeon, H. J., Lim, D., So, E., Kim, S., Jeong, J., Song, M., & Lee, H. J. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.011 · Cited by 13
Ray, S., Moonshi, S. S., & Ta, H. T. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403162 · Cited by 18
Dong, P.-S., Zhou, Y., Yu, W., Zou, J.-H., Tian, Y., Fan, J., Zheng, D., & Zhao, Y. (2025) · Science China Materials · doi:10.1007/s40843-025-3438-6 · Cited by 13
Data-driven statistical modeling of the emergent behavior of biohybrid microrobots
Leaman, E. J., Sahari, A., Traoré, M. A., Geuther, B. Q., Morrow, C. M., & Behkam, B. (2020) · APL Bioengineering · doi:10.1063/1.5134926 · Cited by 13
Amplitude-phase description of stochastic neural oscillators across the Hopf bifurcation
Powanwe, A. S., & Longtin, A. (2021) · Physical Review Research · doi:10.1103/physrevresearch.3.033040 · Cited by 16
Chun, K., Stephens, K., Wang, S., Tsao, C., Payne, G. F., & Bentley, W. E. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01703-2 · Cited by 10
Nie, C., Tao, F., Wang, P., Jiang, X., Peng, P., Yang, X., Wang, J., Yu, L., Guo, Y., & Peng, L. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154567 · Cited by 10
Research progress on intratumoral microorganisms in renal cancer
Zhang, J., Lou, K., Chi, J., Wu, J., Fan, X., & Cui, Y. (2025) · World Journal of Urology · doi:10.1007/s00345-024-05403-5 · Cited by 10
Bacterial-based drug delivery systems: A new way to combat infectious disease
TabibzadehTehrani, P., Nazari, M., Rastgoo, P., Bolouri, N. S., HeydariKarsaf, R., Hadiani, A., & Mohsenipour, Z. (2025) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2025.100205 · Cited by 12
Yang, Q., Xiang, W. D., Khan, A., Salama, E., Kulshrestha, S., Ji, J., Wu, Y., & Li, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2531198 · Cited by 11
Metabolic interplay drives population cycles in a cross-feeding microbial community
Ross, T. D., Im, H., Keogh, B. G., Klausmeier, C. A., & Venturelli, O. S. (2025) · Nature Communications · doi:10.1038/s41467-025-63986-y · Cited by 15
Liu, Y., Yao, J., Deng, J., Zhou, M., Shen, K., Sun, S., Gao, X., Zhang, Q., & Xu, H. (2026) · Advanced Science · doi:10.1002/advs.202517730 · Cited by 12
Modelling Bacteria-Inspired Dynamics with Networks of Interacting Chemicals
Bánsági, T., & Taylor, A. F. (2019) · Life · doi:10.3390/life9030063 · Cited by 10
Bahuguna, A., & Dubey, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188956 · Cited by 11
Kinetic temperature and pressure of an active Tonks gas
Schiltz-Rouse, E., Row, H., & Mallory, S. A. (2023) · Physical review. E · doi:10.1103/physreve.108.064601 · Cited by 9
Similarities in Structure and Function of UDP-Glycosyltransferase Homologs from Human and Plants
Lethe, M. C. L., Paris, V., Wang, X., & Chan, C. T. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052782 · Cited by 9
Srivastava, R., González-Prieto, C., Lynch, J. P., Muscolo, M. E., Lin, C. Y., Brown, M. A., Lemos, L., Shrestha, A., Osburne, M. S., Leong, J. M., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae374 · Cited by 9
Hybrid centralized/decentralized control of a network of bacteria-based bio-hybrid microrobots
Leaman, E. J., Geuther, B. Q., & Behkam, B. (2019) · Journal of Micro-Bio Robotics · doi:10.1007/s12213-019-00116-0 · Cited by 9
Prospect of bacteria for tumor diagnosis and treatment
Xu, Y., Zhao, C., Ma, X., & Zhang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121215 · Cited by 9
Han, X., Yang, J., Zeng, F., Weng, J., Zhang, Y., Peng, Q., Shen, L., Ding, S., Liu, K., & Gao, Y. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.008 · Cited by 9
Dynamic Gene Expression Mitigates Mutational Escape in Lysis-Driven Bacteria Cancer Therapy
Liguori, F., Pellicciotta, N., Milanetti, E., Windemuth, S. X., Ruocco, G., Leonardo, R. D., & Danino, T. (2024) · BioDesign Research · doi:10.34133/bdr.0049 · Cited by 11
Self-citationUnraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier
Wang, S., Li, S., Zhang, M., Liu, R., Ye, X., Mao, S., Yu, J., Xie, X., & Tan, W. (2025) · Research · doi:10.34133/research.0744 · Cited by 13
A genetic safeguard for eliminating target genes in synthetic probiotics in a gut environment
Nguyen, N., Wang, M., Li, L., & Chan, C. T. Y. (2025) · iScience · doi:10.1016/j.isci.2025.113027 · Cited by 15
Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation
Wang, Y., Chen, C., Xiao, X. H., Kang, Y., He, J., Beloqui, A., & Xu, Y. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115741 · Cited by 10
Synthetic biology approaches to enhance cancer immune responses
Liu, S., Zhong, Z., Tu, Q., & Jin, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1698158 · Cited by 10
Hurt, R. C., Buss, M. T., Duan, M., Wong, K., You, M. Y., Sawyer, D. P., Swift, M., Dutka, P., Barturen‐Larrea, P., Mittelstein, D. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.26.441537 · Cited by 10
Engineering microbial living therapeutics
Pedrolli, D. B., Ribeiro, N. V., Squizato, P. N., Cozetto, D. A., de Jesus, V. N., Freire, P. J. C., Lins, M. R. C. R., & Corrêa, G. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00008-3 · Cited by 6
Application of Bacterial Whole-Cell Biosensors in Health
Song, Y., Rampley, C. P. N., Chen, X., Du, F., Thompson, I. P., & Huang, W. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-23217-7_136 · Cited by 10
Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues
Chu, B., Yang, Y., Tang, J., Song, B., He, Y., & Wang, H. (2022) · Angewandte Chemie · doi:10.1002/ange.202208422 · Cited by 8
Gut microbiome and neurosurgery: Implications for treatment
Willman, J., Willman, M., Reddy, R., Fusco, A. F., Sriram, S., Mehkri, Y., Charles, J. H., Goeckeritz, J., & Lucke-Wold, B. P. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.139 · Cited by 10
Impact of the host microbiota on fungal infections: New possibilities for intervention?
Chow, E. W. L., Pang, L. M., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114896 · Cited by 11
Synthetic phylogenetically diverse communities promote denitrification and stability
Zhou, M., Guan, X., Deng, T., Hu, R., Qian, L., Yang, X., Wu, B., Li, J., He, Q., Shu, L., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116184 · Cited by 7
Photocatalytic scaffolds enhance anticancer performances of bacterial consortium AUN
Miyahara, M., Doi, Y., Takaya, N., & Miyako, E. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156378 · Cited by 8
Zhao, S., Li, H., Wang, Q., Liu, R., Lai, X., Sumpradit, T., Khan, A., & Qu, J. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.123037 · Cited by 7
Bioengineered therapeutic systems for improving antitumor immunity
Cao, Y., Yan, W., Yi, W., Yin, Q., & Li, Y. (2024) · National Science Review · doi:10.1093/nsr/nwae404 · Cited by 10
Nanobots: A Revolutionary Technology in the Development of Pharmaceuticals
Agrawal, R., Deshmukh, R., Garg, A., Mali, S. N., Prajapati, B. G., & Singh, K. (2024) · BioNanoScience · doi:10.1007/s12668-024-01632-5 · Cited by 7
Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy
Kuhl, G. C., & Tangney, M. (2025) · Cancers · doi:10.3390/cancers17050723 · Cited by 9
Li, Y., Wang, X., Ye, F., Hong, X., Chen, Y., Huang, J., Liu, J., Huang, X., Liang, L., Guo, Y., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118046 · Cited by 7
Chang, X., Liu, X., Wang, X., Ma, L., Liang, J., & Li, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1545334 · Cited by 9
Wang, A. Y. L., Aviña, A. E., Liu, Y., & Kao, H. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf068 · Cited by 10
Bacteria as living biosensors for DNA
O’Connor, K., Steppe, P., Worthley, D. L., Hasty, J., & Cooper, R. M. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00369-4 · Cited by 11
Self-citationEngineered nano-bacteria hybrids for precision cancer immunotherapy
Yu, L., Qiu, Y., Li, R., Xu, Z. C., & Li, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102484 · Cited by 10
Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment
Canowitz, A., Kamble, N. H., Muck, N., Kaur, K., Garay, N., Bellala, P., Gabani, B. B., & Kotagiri, N. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114720 · Cited by 13
Zou, H., Ding, Y., Shang, J., Ma, C., Li, J., Yang, Y., Cui, X., Zhang, J., Ji, G., & Wei, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1251211 · Cited by 8
Cui, W., Lin, X., Hu, R., Chen, H., Xiao, P., Tao, M., Suo, F., Han, L., & Zhou, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137781 · Cited by 8
Protecting honey bees through microbiome engineering
Navarro-Escalante, L., Ashraf, A. H. M. Z., Leonard, S. P., & Barrick, J. E. (2025) · Current Opinion in Insect Science · doi:10.1016/j.cois.2025.101416 · Cited by 11
Nanorobots for improved theranostic applications
Anzar, N., Yadav, N., & Narang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85785-7.00002-4 · Cited by 7
Bottom-Up Synthetic Biology Using Cell-Free Protein Synthesis
Yue, K., Li, Y., Cao, M., Shen, L., Gu, J., & Kai, L. (2023) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2023_232 · Cited by 10
Intervening in disease through genetically-modified bacteria
Ferreira, A. K., Mambelli, L. I., & Pillai, S. Y. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.017 · Cited by 7
Designing Spatially Distributed Gene Regulatory Networks To Elicit Contrasting Patterns
Tei, M., Perkins, M. L., Hsia, J., Arcak, M., & Arkin, A. P. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00377 · Cited by 7
De-Novo -Designed Translational Repressors for Multi-Input Cellular LogicPreprint
Kim, J., Zhou, Y., Carlson, P. D., Teichmann, M., Simmel, F. C., Silver, P. A., Collins, J. J., Lucks, J. B., Yin, P., & Green, A. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/501783 · Cited by 7
Multiplexed biosensors for precision bacteria tropism in vivoPreprint
Chien, T., Harimoto, T., Kepecs, B., Gray, K., Coker, C., Pu, K., Azad, T., & Danino, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/851311 · Cited by 7
Self-citationResearch and application of intelligent diagnosis and treatment engineering bacteria
Zhao, N., Chen, J., Shi, J., Gao, Y., Li, L., & Dong, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1524376 · Cited by 7
Metadata
- Authors
- Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., & Hasty, J.
- Affiliations
- University of California San Diego (US)
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Corresponding author
- Hasty, Jeff
- ORCID
- Venue
- Nature
- Published
- 2016-07-20
- Volume
- 536
- Issue
- 7614
- Pages
- 81-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5048415
- OpenAlex
- W2480697384
- Cited by
- 784
- References
- 31
- Citations by year
- 2026: 97 · 2025: 107 · 2024: 95 · 2023: 87 · 2022: 73 · 2021: 71 · 2020: 82 · 2019: 59 · 2018: 55 · 2017: 43 · 2016: 12
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PMC
- Funders
- Howard Hughes Medical Institute
- University of California, San Diego
- National Cancer Institute (K99CA197649, R00CA197649, DP1CA174420, P30CA014051)
- National Institute of General Medical Sciences (P50GM085764, R01GM069811)
- National Institute of Environmental Health Sciences (P30ES002109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial lysis, quorum sensing, synthetic biology, Salmonella, pulsatile drug delivery, cancer therapy, colorectal cancer, liver metastasis, bacterial population dynamics, luminescent reporter, combination chemotherapy, oral administration, living therapeutics
- MeSH terms
- Administration, Oral, Animals, Bacteriolysis, Computer Simulation, Female, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Transplantation, Salmonella, Transplantation, Isogeneic, Colorectal Neoplasms, Drug Delivery Systems, Coculture Techniques, Luminescence, Mice, Quorum Sensing, Synthetic Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.